Using the HSV-tk/GCV system, complete remissions of tumors up to a size of
5 mm in diameter have been reported in mice and rats. In order to examine w
hether larger tumors of clinically relevant size can also be successfully t
reated, we established hepatic and peritoneal tumors consisting of retrovir
ally pretransduced tk-positive CC531 colon adenocarcinoma cells in syngenic
Wag/Ola rats. In this model, we evaluated whether large tumors respond to
therapy under the ideal condition of 100% gene transfer. Within 10 days, GC
V treatment led to a marked regression of the adenocarcinomas. Tumors up to
a size of 4000 mm(3) could be completely eradicated. Passing through sever
al stages of degeneration and cytolytic necrosis, a complete replacement by
fibrous tissue was seen. There was no histological evidence for apoptosis
and cell mediated immunity.
These results suggest that complete regression of tumors of clinically rele
vant size can be achieved by direct toxic effects of the HSV-tk/GCV system
if 100% of the cells are transduced.